// App-Quantinova.ai

: NEUTROPHIL TO LYMPHOCYTE RATIO FOR TRACKING INFLAMMATION AND RECURRENCE IN PATIENTS WITH RECURRENT PERICARDITIS: POST HOC ASSESSMENT OF A PHASE 3 TRIAL, RHAPSODY

Researchers

Presenter

  • Paul Cremer

Principal Investigators

  • Alistair Wheeler

  • Liangxing Zou

  • Fang Fang

  • Bryan Abadie

  • Joshua Saef

  • Massimo Imazio

  • Allan L. Klein

  • John Frank Paolini

Medical Centers

  • Kiniksa Pharmaceuticals (UK), Ltd., London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Obstetrics/Gynecology

Disease

  • Recurrent pericarditis

  • Twin-reversed arterial perfusion

Biomarkers

  • Neutrophil lymphocyte ratio

Drug/Treatment

  • Interleukin

  • Rilonacept

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved